Quantora — Markets, Analysis & Valuation

Valuations are estimates only, produced by transparent models for education and research. This is not financial advice. Verify before trading.

Eli Lilly and Co — Valuation Dashboard

Download PDF report Company page

MARKET PRICE

1,112.00

DCF (FCFF)

108.64

-90.23% vs market

COMPARABLES

n/a

DIVIDEND (DDM)

n/a

ASSET-BASED

n/a

QUALITY SCORE

…

Implied values per model vs market — models disagree by design; each makes different assumptions. Estimates only.

Composite signal

Watch

Health Care · sig-v0.1 · confidence 25/100

Value

Quality

Momentum

Low-vol

Composite 51 (50th percentile in Health Care)

MOS

Value

Band

Trend

The model flags: MOS -933.3% vs 50% needed [fail] · relative value [fail] · composite 50 pct, band out [fail] · trend confirmed [pass]. Confidence 25/100.

Educational model classification — not a buy/sell recommendation, and not personalised. Verify before trading.

As of 2026-06-17 06:00 UTC.

Assumptions

Year-1 revenue growth %

Terminal growth %

Target operating margin %

Tax rate %

WACC override % (blank = CAPM)

Defaults derive from the company's statements; risk-free rate source: FRED:DGS10 (4.43 %). Any change is recorded as a user override in the audit trail.

Inputs from statements

Revenue (latest FY)	65.18B
Operating margin	0.0 %
Net debt	-7.27B
Diluted shares	899.30M
Beta	1.00 (default)
Market price	1,112.00

Fundamentals as of 2025-12-31 · Source: DEMO

INTRINSIC VALUE / SHARE

108.64

MARKET PRICE

1,112.00

UPSIDE

-90.23%

MARGIN OF SAFETY

-923.6 %

Enterprise value 90.43B · Equity value 97.70B · WACC 9.20 % · Formula v1.0 · Audit run 045036a1

Total debt not found on the balance sheet — net debt treated as cash-only; equity bridge unreliable.

No beta available — defaulting to 1.0.

Bull/base/bear scenarios, sensitivity tables and the comparable / dividend / asset-based models require the Pro tier — the DCF summary above is included in Free. (Billing integration pending; tiers live in the subscriptions table.)